Uncategorized Bernstein Maintains a Buy Rating on MicroStrategy (NASDAQ:MSTR) With a $600 PT Post Content
Uncategorized RBC Capital Maintains a Buy Rating on Schlumberger Limited (SLB) With a $48 PT Post Content
Uncategorized Citi Maintains a Buy Rating on Trip.com Group (TCOM), Sets a $78 Price Target Post Content
Uncategorized AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals Post Content